Method for treating obesity and type ii diabetes by adjusting the circadian rhythm of human growth hormone
WO9640132A1
Method for inhibiting neoplastic disease in mammals
US5700800A
Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
ZA9505415B
Administration of pirenzepine methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
ZA9505192B
Methods for the determination and adjustment of prolactin daily rhythms
US5714519A
Method for regulating glucose metabolism
US5565454A
Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
